Paper Details

  1. Home
  2. Paper Details

Pregabalin add-on for drug-resistant partial epilepsy.

Author: HemmingKarla, MarsonAnthony G, PulmanJennifer

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This review updates a previous Cochrane review on the effectiveness of pregabalin for treating epilepsy. While new antiepileptic drugs have been developed, limited evidence supports pregabalin's efficacy in this context.
Paper Details　
Original Abstract of the Article :
Epilepsy is a common chronic neurological disease with an estimated prevalence of 1% in the UK. Approximately one third of these people continue to have seizures despite drug treatment. In order to try to improve outcomes a number of new antiepileptic drugs have been developed and pregabalin is one ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD005612.pub3

データ提供：米国国立医学図書館（NLM）

Pregabalin: A Potential Solution for Drug-Resistant Epilepsy

Epilepsy, a neurological disorder characterized by recurrent seizures, can be a challenging condition to manage, especially in cases of drug resistance. This study explores the potential of pregabalin, a medication traditionally used for neuropathic pain, as an adjunctive therapy for drug-resistant partial epilepsy.

The researchers reviewed the available evidence on the use of pregabalin as an add-on therapy for drug-resistant partial epilepsy. While the evidence base is limited, the available data suggests that pregabalin may offer some benefit in reducing seizure frequency in patients with drug-resistant epilepsy.

Pregabalin: A New Path for Drug-Resistant Epilepsy?

The study highlights the potential of pregabalin as an adjunctive therapy for drug-resistant epilepsy. While the evidence is limited, the available data suggests that pregabalin may offer some benefit in reducing seizure frequency. Further research is needed to fully understand the efficacy and safety of pregabalin in this context.

Managing Epilepsy: A Collaborative Journey Towards Seizure Control

The study emphasizes the importance of ongoing research into new and effective treatments for epilepsy. The exploration of pregabalin’s potential as an adjunctive therapy for drug-resistant epilepsy represents a promising avenue for improving seizure control. The study also underscores the need for a collaborative approach between clinicians, researchers, and patients in finding the best treatment strategies for epilepsy.

Dr. Camel's Conclusion

The desert of epilepsy research is vast and unforgiving, with many patients facing the challenge of drug resistance. This study offers a glimmer of hope, highlighting the potential of pregabalin as an adjunctive therapy for drug-resistant epilepsy. The research reminds us that the search for effective treatments for epilepsy continues, and it's crucial to be open to new possibilities and approaches to manage this complex condition.

Date :
  1. Date Completed 2014-09-30
  2. Date Revised 2022-03-10
Further Info :

Pubmed ID

24623260

DOI: Digital Object Identifier

10.1002/14651858.CD005612.pub3

Related Literature

Article Analysis
・Effective treatment of epilepsy
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.